Results 91 to 100 of about 7,425 (188)
Background This study compared the effectiveness of cabergoline and hydroxychloroquine in preventing ovarian hyperstimulation syndrome (OHSS) in patients with polycystic ovary syndrome (PCOS) undergoing controlled ovarian stimulation.
Elnaz Salari +4 more
doaj +1 more source
The dopamine agonist cabergoline has been used to treat prolactinomas, Parkinson’s disease, Cushing’s disease, and sexual dysfunction. However, its clinical use was severely curtailed when it was found that patients taking cabergoline had an increased ...
Suck Won Kim (1993195) +3 more
core +1 more source
Stability of cabergoline in fox baits in laboratory and field conditions
Cabergoline is a potent inhibitor of prolactin release and a potential fertility control agent for foxes. To understand how cabergoline could behave in baits deployed for fox control, we conducted laboratory and field trials to investigate the stability ...
Kirkwood, R (15510188) +2 more
core +2 more sources
Background & aim: The anti-inflammatory effects of cabergoline have been documented in various studies. The purpose of the present study was to evaluate the effects of cabergoline administration (as a potent D2 agonist) on clinical aspects and immune ...
E Shaftaloud +2 more
doaj
CABERGOLINE EFFECTS ON MARE ESTROUS BEHAVIOR, CYCLICITY, AND ENDOCRINE PROFILES
An abstract of the thesis of Casie S. Bass, for the Masters of Science degree in Animal Science, presented on April 7, 2010 at Southern Illinois University Carbondale. TITLE: CABERGOLINE EFFECTS ON MARE ESTROUS BEHAVIOR, CYCLICITY, AND ENDOCRINE PROFILES
Bass, Casie Shantel
core +1 more source
To investigate whether the administration of the long-lasting dopaminergic drug, cabergoline, improves endocrine and clinical features of women with polycystic ovary syndrome (PCOS).Twenty-nine women participated in the study: 14 women with clinical and ...
A. M. Paoletti +11 more
core +1 more source
Cabergoline is a dopaminergic agonist relatively specific for the D2 receptor and much longer-acting than other dopamine agonists. We conducted a randomized, placebo-controlled, double-blind study of cabergoline in 188 levodopa/carbidopa-treated patients
Hutton, J. T. +13 more
core +1 more source
Several international studies have suggested that treatment of early Parkinsonʼs disease (PD) with a dopamine agonist instead of levodopa delays the occurrence of motor complications.
Utsumi, Hiroya +1 more
core
Response to Treatment in a sample of Iraqi Patients with Prolactinoma
Background: Hyperprolactinemia is a common endocrine abnormality caused by physiological factors like pregnancy and lactation, drug-induced factors like antipsychotics, pituitary adenomas that secrete prolactin, or stalk compression or section that ...
Rana Kareem Mohammed +2 more
doaj +1 more source
This research designed a simplified, sensitive electro-chemical procedure to detect cabergoline by a means of a screen-priented electrode (SPE) modified with Fe2MoO6 magnetic nanocomposite (Fe2MoO6/SPE).
Van Le, Q. +9 more
core

